The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Nov. 12, 2013
Applicant:

Invectys, Paris, FR;

Inventors:

Maria de las Nieves Loustau, Paris, FR;

Julien Caumartin, Le Vesinet, FR;

Pierre Langlade-Demoyen, Neuilly sur Seine, FR;

Assignee:

INVECTYS, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/34 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/34 (2013.01); A61K 39/0005 (2013.01); C07K 14/70539 (2013.01); C07K 16/2833 (2013.01); A61K 2039/53 (2013.01); A61K 2039/585 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract

An antibody or antigen-binding fragment thereof which specifically binds the α3 domain of a HLA-G protein, in particular binds the β2-microglobulin free HLA-G protein exhibiting an α3 domain. The nucleic acid molecules encoding a human HLA-G α3 domain polypeptide, which is selected from a group of specific sequences, and vectors for the cloning and/or expression of such nucleic acid molecules, recombined cells or cell lines and compositions for use in a host in need thereof to interfere with and neutralize the immune down-regulation due to HLA-G proteins, and/or improving or treating conditions showing HLA-G+ lesions, and/or improving or treating a neoplasic condition or disease. A method of producing the antibody or antigen-binding fragment thereof, immunogenic compositions for use to elicit in a host an immune response against the α3 domain of HLA-G protein, and an in vitro method for detecting HLA-G protein in a sample are also described.


Find Patent Forward Citations

Loading…